<p>Panel A shows a Western blot analysis of PPAR-α expression (n=6 each group). FGF21 mRNA abundance (B) and GLUT-2 protein expression level (C) in the liver extracts were quantified by real-time PCR and Western blot analysis, respectively (n=6 each group). **P<0.01, ***P<0.001 <i>vs</i> STD; <sup>#</sup> P<0.05, <sup># #</sup> P<0.01, <sup># # #</sup> P<0.001 <i>vs</i> HFD.</p
oxidation and ketone body production in animals. In this study, we investigated the role of FGF21 in...
oxidation and ketone body production in animals. In this study, we investigated the role of FGF21 in...
Fibroblast growth factor 21 (FGF21) stimulates fatty acid oxidation and ketone body production in an...
Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic l...
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver...
Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease. Insulin r...
<p>Representative Western blot of PPAR-γ (A) is shown (n=5 each group). Panel B shows real-time PCR ...
<p>Panels A and B are the results of real-time PCR for HMGB-1 and TLR4, respectively, in liver extra...
<p>Paraffin-embedded sections of the liver (n=4 each group) were stained with hematoxylin-eosin (A) ...
<p>Quantitative RT-PCR of RNA from livers of chow-fed rats, rats fed an HFrD for 8 weeks and rats fe...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
oxidation and ketone body production in animals. In this study, we investigated the role of FGF21 in...
oxidation and ketone body production in animals. In this study, we investigated the role of FGF21 in...
Fibroblast growth factor 21 (FGF21) stimulates fatty acid oxidation and ketone body production in an...
Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic l...
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver...
Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease. Insulin r...
<p>Representative Western blot of PPAR-γ (A) is shown (n=5 each group). Panel B shows real-time PCR ...
<p>Panels A and B are the results of real-time PCR for HMGB-1 and TLR4, respectively, in liver extra...
<p>Paraffin-embedded sections of the liver (n=4 each group) were stained with hematoxylin-eosin (A) ...
<p>Quantitative RT-PCR of RNA from livers of chow-fed rats, rats fed an HFrD for 8 weeks and rats fe...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
oxidation and ketone body production in animals. In this study, we investigated the role of FGF21 in...
oxidation and ketone body production in animals. In this study, we investigated the role of FGF21 in...
Fibroblast growth factor 21 (FGF21) stimulates fatty acid oxidation and ketone body production in an...